Bei Li
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 1%
- Nanoplatforms for cancer theranostics
Papers in
- Immunology 36
- Immunotherapy and Immune Responses 11
- Immune cells in cancer 11
- Biomaterials 19
- Nanoparticle-Based Drug Delivery 16
Bei Li
152 papers receiving 6.0k citations
Hit Papers
Peers
Comparison fields: 5 of 143
- Biomaterials 800
- Biomedical Engineering 2.1k
- Renewable Energy, Sustainability and the Environment 722
- Immunology 915
- Materials Chemistry 1.8k
Countries citing papers authored by Bei Li
This map shows the geographic impact of Bei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bei Li more than expected).
Fields of papers citing papers by Bei Li
This network shows the impact of papers produced by Bei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bei Li. The network helps show where Bei Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bei Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2024 | 21 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 18 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 7 | |
| 8 | 2023 | 34 | |
| 9 | STING mediates hepatocyte pyroptosis in liver fibrosis by Epigenetically activating the NLRP3 inflammasome Hit paper breakdown → | 2023 | 104 |
| 10 | 2023 | 1 | |
| 11 | 2023 | 20 | |
| 12 | 2022 | 1 | |
| 13 | 2020 | 24 | |
| 14 | 2020 | 22 | |
| 15 | 2017 | 12 | |
| 16 | 2015 | 42 | |
| 17 | 2015 | 65 | |
| 18 | 2013 | 149 | |
| 19 | 2011 | 97 | |
| 20 | 2005 | 26 |
About Bei Li
Bei Li is a scholar working on Immunology, Biomaterials, Virology, Biomedical Engineering and Oncology, having authored 157 papers that have together received 6.0k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (37 papers), Nanoparticle-Based Drug Delivery (16 papers), Advanced Photocatalysis Techniques (12 papers), Advanced Nanomaterials in Catalysis (11 papers), Layered Double Hydroxides Synthesis and Applications (11 papers), Immunotherapy and Immune Responses (11 papers), Immune cells in cancer (11 papers) and Gallbladder and Bile Duct Disorders (9 papers). The work is most often cited by research in Biomaterials (800 citations), Biomedical Engineering (2.1k citations), Renewable Energy, Sustainability and the Environment (722 citations), Immunology (915 citations) and Materials Chemistry (1.8k citations). Bei Li has collaborated with scholars based in China, Macao and Australia. Frequent co-authors include Yunlu Dai, Wei Sang, Zhi Ping Xu, Zhan Zhang, Lisi Xie, Jie Li, Zi Gu, Jie Yan, Hao Tian and Lazhen Shen. Their work appears in journals such as Frontiers in Oncology, Advanced Materials, Frontiers in Immunology, INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY and Small.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.